Human Alloreactive CD4+T Cells as Potent Effector Cells and Sole Mediators of Anti-Tumor Responses in a NOD/SCID Mouse Model for Human Acute Leukemia.

被引：0
|
作者：
Stevanovic, Sanja [1 ]
Griffioen, Marieke [1 ]
Van Schie, Marianke L. J. [1 ]
Willemze, Roelof [1 ]
Falkenburg, J. H. Frederik [1 ]
Nijmeijer, Bart [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 452
页数：1
相关论文
共 50 条
  • [21] Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
    Oh, David Y.
    Kwek, Serena S.
    Raju, Siddharth S.
    Li, Tony
    McCarthy, Elizabeth
    Chow, Eric
    Aran, Dvir
    Ilano, Arielle
    Pai, Chien-Chun Steven
    Rancan, Chiara
    Allaire, Kathryn
    Burra, Arun
    Sun, Yang
    Spitzer, Matthew H.
    Mangul, Serghei
    Porten, Sima
    Meng, Maxwell, V
    Friedlander, Terence W.
    Ye, Chun Jimmie
    Fong, Lawrence
    CELL, 2020, 181 (07) : 1612 - +
  • [22] Decreased homing efficiency of transduced human CD34+cells in the NOD/SCID mouse model.
    Hall, KM
    Horvath, TL
    Cornetta, K
    Abonour, R
    Srour, EF
    BLOOD, 2002, 100 (11) : 487B - 487B
  • [23] Human allograft rejection is mediated by CD4+T cells in SCID mice transplanted with human thymus and liver (THY/LIV SCID mice).
    Sho, M
    Samsonov, DV
    Laning, JC
    Hardin-Young, J
    Sayegh, MH
    Briscoe, DM
    TRANSPLANTATION, 2000, 69 (08) : S298 - S299
  • [24] Generation Of Anti-Tumor CD4+T Helper Cells Using Genetically-Engineered Dendritic Cells Expressing Leukemia-Associated Antigens
    Chinnasamy, Dhanalakshmi
    Muranski, Pawel
    Franco-Colon, Manuel
    Ito, Sawa
    Hensel, Nancy F.
    Bollard, Catherine M.
    Barrett, A. John
    BLOOD, 2013, 122 (21)
  • [25] A novel human CD1d knock-in mouse model demonstrates potent anti-tumor potential of human CD1d-restricted iNKT cells
    Yuan, Weiming
    Wen, Xiangshu
    Rao, Ping
    Cresswell, Peter
    Porcelli, Steven
    Kim, Seil
    Carreno, Leandro
    Lawrenczyk, Agnieszka
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [26] Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity
    Faber, Mary L.
    Oldham, Robyn A. A.
    Thakur, Archana
    Rademacher, Mary Jo
    Kubicka, Ewa
    Dlugi, Theresa A.
    Gifford, Steven A.
    Mckillop, William M.
    Schloemer, Nathan J.
    Lum, Lawrence G.
    Medin, Jeffrey A.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] Failure of Effector Function of Human CD8+ T Cells in NOD/SCID/JAK3-/- Immunodeficient Mice Transplanted with Human CD34+ Hematopoietic Stem Cells
    Sato, Yoshinori
    Takata, Hiroshi
    Kobayashi, Naoki
    Nagata, Sayaka
    Nakagata, Naomi
    Ueno, Takamasa
    Takiguchi, Masafumi
    PLOS ONE, 2010, 5 (10):
  • [28] Targeting human acute myeloid leuliemia with multi-epitope specific naivederived anti-tumor CD4+ T cells
    Chang, Mark Jesse
    Whitehill, Gregory
    Stegennann, Scott
    Scofield, Eric
    Wong, Susan
    Keyvanfar, Keyvan
    Jain, Prachi
    Ito, Sawa
    Chen, Jichun
    Barrett, John
    Muranski, Pavvel
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [29] Provision of CD4+T cell help preferentially enhances anti-tumor immunity of high avidity T cells
    Zhu, Zigiang
    Singh, Vinod
    Bronte, Vincenzo
    Feigenbaum, Lionel
    Hurwitz, Arthur
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [30] Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model
    Hall, KA
    Horvath, TL
    Abonour, R
    Cornetta, K
    Srour, EF
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (04) : 433 - 442
12345